FDA Approval: CEFAZOLIN (CEFAZOLIN SODIUM) — Type 5 - New Formulation or New Manufacturer
Policy FDA-NDA207131 · Infectious Disease
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.